Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

Delayed Quote. Delayed  - 08/23 10:02:04 pm
133 USD   -0.26%
08/23 CIGNA : Revises Policy, Will Cover 3D Mammography for Breast Cancer ..
08/17DJJob Seekers Face Virtual Interviews -- WSJ
08/16DJVIDEO JOB INTER : Hiring for the Selfie Age
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Cigna profit misses Wall Street target

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 01:05pm CEST

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Cigna is the latest health insurer to miss Wall Street's earnings target in the period, following Aetna Inc (>> Aetna Inc.), Coventry Health Care (>> Coventry Health Care, Inc.) and Humana Inc (>> Humana Inc.).

Cigna did raise its full-year earnings forecast.

Net income fell to $371 million, or $1.28 per share, from $413 million, or $1.51 per share, a year earlier.

Excluding special items, Cigna's earnings of $1.28 per share fell 2 cents below the analysts' average estimate, according to Thomson Reuters I/B/E/S.

Revenue jumped 25 percent to $6.79 billion, helped by the acquisition of Medicare specialist HealthSpring.

Profit in the main healthcare segment rose 6.5 percent to $262 million, helped by rising membership in its plans.

But earnings in its disability and life segment fell 16 percent to $65 million. The company cited strategic investments in its disability management programs as a factor pushing down profit.

Cigna forecast 2012 earnings of $5.20 to $5.55 per share. It previously projected $5.00 to $5.40. Analysts have been looking for $5.41.

(Reporting by Lewis Krauskopf in New York; Editing by Lisa Von Ahn)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
08/23 CIGNA : Revises Policy, Will Cover 3D Mammography for Breast Cancer Screening
08/17DJJob Seekers Face Virtual Interviews -- WSJ
08/16DJVIDEO JOB INTERVIEWS : Hiring for the Selfie Age
08/16DJAetna Withdraws From Most of Its Health Exchanges
08/13DJANTHEM : No Anthem-Cigna Ruling This Year -- WSJ
08/12DJANTHEM : Ruling on Anthem-Cigna Merger Unlikely in 2016, Judge Says -- Update
08/12 U.S. judge in Anthem merger trial sets trial for November 21, plans ruling by..
08/12DJANTHEM : Ruling on Anthem-Cigna Merger Unlikely in 2016, Judge Says
08/12DJRuling on Anthem-Cigna Merger Won't Come This Year
08/10DJJudge to Start Aetna-Humana Merger Trial Dec. 5
More news
Sector news : Managed Healthcare - NEC
08/23DJUNITEDHEALTH : Correction to 'Fugitive Tech CEO Kobi Alexander Returning to U.S'
08/23DJUNITEDHEALTH : Fugitive Tech CEO Kobi Alexander Returning to U.S. in Plea Deal i..
08/23DJVERINT : Fugitive Tech CEO Alexander Returning to U.S. in Plea Deal
08/18DJAETNA : Clinton Pushed From Left and Right on Health Care
08/18DJAETNA : Obama Health Law's Instability Is Intrinsic -- WSJ
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
08/22 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2016 Update
08/19 Aetna Admits Managed Care Beats Insurance On Obamacare Exchanges
08/17 The Curious Case Of Aetna's Obamacare Exit
08/17 Tracking David Einhorn's Portfolio - Q2 2016 Update
08/15 GE Happy To Be Unimportant
Advertisement
Financials ($)
Sales 2016 39 677 M
EBIT 2016 3 175 M
Net income 2016 1 898 M
Debt 2016 1 672 M
Yield 2016 0,02%
P/E ratio 2016 17,39
P/E ratio 2017 14,06
EV / Sales 2016 0,90x
EV / Sales 2017 0,82x
Capitalization 34 214 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 152 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION-8.87%34 214
UNITEDHEALTH GROUP INC20.78%135 325
AETNA INC11.13%42 149
ANTHEM INC-6.97%34 139
HUMANA INC1.07%26 895
CENTENE CORP7.34%12 061
More Results